HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
2-(4-Bromo-3-methylphenyl)-5-methyl-1,3,4-oxadiazole → 6,2'-Dimethyl-4'-(5-methyl-[1,3,4]oxadiazol-2-yl)-biphenyl-3-carboxylic acid cyclopropylmethyl-amide
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | 2-(4-Bromo-3-methylphenyl)-5-methyl-1,3,4-oxadiazole | HCID 11436693 | — |
| Edukt | N-cyclopropylmethyl-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide | HCID 21914588 | — |
| Produkt | 6,2'-Dimethyl-4'-(5-methyl-[1,3,4]oxadiazol-2-yl)-biphenyl-3-carboxylic acid cyclopropylmethyl-amide | HCID 10067151 | — |
Reaktionsschritte
The title compound was prepared using 2-(4-bromo-3-methylphenyl)-5-methyl-[1,3,4]oxadiazole and N-cyclopropylmethyl-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]-dioxaborolan-2-yl)benzamide (Intermediate 17).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US07425555B2 |
| Quelldatensatz | uspto-grants-2008_09 |
| ORD ID | ord-087df855699d41b6b593c6299ddb8f65 |
| Quellennotiz | uspto-grants-2008_09 |